Mexico’s Papel San Francisco has invested in an Advantage DCT 100TS tissue production machine at its site in Mexicali.
Supplied by Valmet, start-up is planned for the third quarter of 2020 and will increase the company’s standard tissue production capacity by 30,000tpy.
It will have a width of 2.8m and a design speed of 2,200m/min, and the scope of delivery will comprise an Advantage DCT 100TS tissue machine.
The machine will be equipped with OptiFlo headbox and cast alloy Yankee cylinder.
Papel San Francisco was also the first company to start up an Advantage NTT line in 2013.
Dario Palma y Meza Espinoza, operational director, Papel San Francisco, said the line is “the most efficient and best choice” for the grades it needs to produce.
“It is also in our philosophy to go for low energy consumption and lowest possible emissions to air and water.
“With this new tissue line, we expect to achieve the best tissue quality combined with lowest energy consumption.”
Papel San Francisco started up their first tissue machine in 1980.
In the past 35 years, it has grown steadily and today operates six tissue machines with a yearly capacity of 180,000 tonnes of tissue products.
Valmet has previously delivered four tissue machines to the company; three Advantage DCT machines were started up in 2006, 2009 and 2018.
Tissue World Magazine is part of the Informa Markets Division of Informa PLC
Tissue World Magazine is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.